Workflow
源头治理“回流药”
Jing Ji Ri Bao·2025-09-25 00:07

Core Viewpoint - The National Medical Insurance Administration has showcased the effectiveness of "code-based supervision" in combating the illegal circulation of drugs, particularly focusing on the issue of "returned drugs" which are resold through illicit channels after being repackaged or having their information altered [1] Group 1: Regulatory Measures - From July 1, all medical insurance designated institutions are required to scan the unique "electronic ID" traceability code of each drug box during sales, ensuring traceability of drug sources and destinations [1] - The initiative aims to eliminate returned drugs and associated fraudulent insurance claims by enhancing the monitoring of drug traceability codes [1] Group 2: Future Actions - There is a call for further strengthening of drug traceability code supervision and rigorous investigation of abnormal medical insurance card drug purchases [1] - The plan includes enhancing inter-departmental joint law enforcement to impose severe penalties on drug traffickers and medical institutions involved in the illicit drug trade [1] - Raising public legal awareness is also emphasized to establish a robust safety barrier for the public's medication [1]